A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MICHALUART, P. et al. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Therapy, v. 15, n. 10, p. 676-684, 2008Tradução . . Disponível em: https://doi.org/10.1038/cgt.2008.35. Acesso em: 12 out. 2024.
APA
Michaluart, P., Abdallah, K. A., Lima, F. D., Smith, R., Moysés, R. A., Coelho, V., et al. (2008). Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Therapy, 15( 10), 676-684. doi:10.1038/cgt.2008.35
NLM
Michaluart P, Abdallah KA, Lima FD, Smith R, Moysés RA, Coelho V, Victora GD, Socorro-Silva A, Volsi EC, Zárate-Bladés CR, Ferraz AR, Barreto AK, Chammas MC, Gomes R, Gebrim E, Arakawa-Sugueno L, Fernandes KP, Lotufo PA, Cardoso MR, Kalil J, Silva CL. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck [Internet]. Cancer Gene Therapy. 2008 ; 15( 10): 676-684.[citado 2024 out. 12 ] Available from: https://doi.org/10.1038/cgt.2008.35
Vancouver
Michaluart P, Abdallah KA, Lima FD, Smith R, Moysés RA, Coelho V, Victora GD, Socorro-Silva A, Volsi EC, Zárate-Bladés CR, Ferraz AR, Barreto AK, Chammas MC, Gomes R, Gebrim E, Arakawa-Sugueno L, Fernandes KP, Lotufo PA, Cardoso MR, Kalil J, Silva CL. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck [Internet]. Cancer Gene Therapy. 2008 ; 15( 10): 676-684.[citado 2024 out. 12 ] Available from: https://doi.org/10.1038/cgt.2008.35
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MICHALUART, Pedro et al. Phase I/II trial of DNA-HSP65 immunotherapy for advanced squamous cell carcinoma of the head and neck: toxicity and response. Journal of immunotherapy. Hagerstown: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ovidsp.tx.ovid.com/sp-3.12.0b/ovidweb.cgi?WebLinkFrameset=1&S=OGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&returnUrl=ovidweb.cgi%3fMain%2bSearch%2bPage%3d1%26S%3dOGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCOBOFOKMJ00%2ffs046%2fovft%2flive%2fgv023%2f00002371%2f00002371-200711000-00009.pdf&filename=Abstracts+for+the+22nd+Annual+Scientific+Meeting+of+the+International+Society+for+Biological+Therapy+of. Acesso em: 12 out. 2024. , 2007
APA
Michaluart, P., abdallah, K., Lima, F. D., Smith, R. B., Moyses, R. A., Coelho, V., et al. (2007). Phase I/II trial of DNA-HSP65 immunotherapy for advanced squamous cell carcinoma of the head and neck: toxicity and response. Journal of immunotherapy. Hagerstown: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ovidsp.tx.ovid.com/sp-3.12.0b/ovidweb.cgi?WebLinkFrameset=1&S=OGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&returnUrl=ovidweb.cgi%3fMain%2bSearch%2bPage%3d1%26S%3dOGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCOBOFOKMJ00%2ffs046%2fovft%2flive%2fgv023%2f00002371%2f00002371-200711000-00009.pdf&filename=Abstracts+for+the+22nd+Annual+Scientific+Meeting+of+the+International+Society+for+Biological+Therapy+of
NLM
Michaluart P, abdallah K, Lima FD, Smith RB, Moyses RA, Coelho V, Victora GD, Silva AS, Volsi EC, Kalil Filho JE, Bladés CRZ, Ferraz AR, Barreto AK, Chammas MC, Gomes RL, Gebrim E, Lica A-S, Fernandes KP, Lotufo PA, Cardoso MR, Silva CL. Phase I/II trial of DNA-HSP65 immunotherapy for advanced squamous cell carcinoma of the head and neck: toxicity and response [Internet]. Journal of immunotherapy. 2007 ; 30( 8): 898.[citado 2024 out. 12 ] Available from: http://ovidsp.tx.ovid.com/sp-3.12.0b/ovidweb.cgi?WebLinkFrameset=1&S=OGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&returnUrl=ovidweb.cgi%3fMain%2bSearch%2bPage%3d1%26S%3dOGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCOBOFOKMJ00%2ffs046%2fovft%2flive%2fgv023%2f00002371%2f00002371-200711000-00009.pdf&filename=Abstracts+for+the+22nd+Annual+Scientific+Meeting+of+the+International+Society+for+Biological+Therapy+of
Vancouver
Michaluart P, abdallah K, Lima FD, Smith RB, Moyses RA, Coelho V, Victora GD, Silva AS, Volsi EC, Kalil Filho JE, Bladés CRZ, Ferraz AR, Barreto AK, Chammas MC, Gomes RL, Gebrim E, Lica A-S, Fernandes KP, Lotufo PA, Cardoso MR, Silva CL. Phase I/II trial of DNA-HSP65 immunotherapy for advanced squamous cell carcinoma of the head and neck: toxicity and response [Internet]. Journal of immunotherapy. 2007 ; 30( 8): 898.[citado 2024 out. 12 ] Available from: http://ovidsp.tx.ovid.com/sp-3.12.0b/ovidweb.cgi?WebLinkFrameset=1&S=OGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&returnUrl=ovidweb.cgi%3fMain%2bSearch%2bPage%3d1%26S%3dOGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCOBOFOKMJ00%2ffs046%2fovft%2flive%2fgv023%2f00002371%2f00002371-200711000-00009.pdf&filename=Abstracts+for+the+22nd+Annual+Scientific+Meeting+of+the+International+Society+for+Biological+Therapy+of